A GLP-1 receptor agonist conjugated to an albumin-binding domain for extended half-life
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A GLP-1 receptor agonist conjugated to an albumin-binding domain for extended half-life
Authors
Keywords
-
Journal
BIOPOLYMERS
Volume 102, Issue 3, Pages 252-259
Publisher
Wiley
Online
2014-02-19
DOI
10.1002/bip.22474
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Site-Specific Radiometal Labeling and Improved Biodistribution Using ABY-027, A Novel HER2-Targeting Affibody Molecule-Albumin-Binding Domain Fusion Protein
- (2013) A. Orlova et al. JOURNAL OF NUCLEAR MEDICINE
- Glucagon-like peptides 1 and 2 in health and disease: A review
- (2013) Chinmay S. Marathe et al. PEPTIDES
- Site-Specific PEGylated Exendin-4 Modified with a High Molecular Weight Trimeric PEG Reduces Steric Hindrance and Increases Type 2 Antidiabetic Therapeutic Effects
- (2012) Tae Hyung Kim et al. BIOCONJUGATE CHEMISTRY
- GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus
- (2012) Juris J. Meier Nature Reviews Endocrinology
- Strategies for extended serum half-life of protein therapeutics
- (2011) Roland E Kontermann CURRENT OPINION IN BIOTECHNOLOGY
- A small bispecific protein selected for orthogonal affinity purification
- (2010) Tove Alm et al. Biotechnology Journal
- Discovery and characterization of taspoglutide, a novel analogue of human glucagon-like peptide-1, engineered for sustained therapeutic activity in type 2 diabetes
- (2010) J. Z. Dong et al. DIABETES OBESITY & METABOLISM
- Insulin-feedback via PI3K-C2α activated PKBα/Akt1 is required for glucose-stimulated insulin secretion
- (2010) Barbara Leibiger et al. FASEB JOURNAL
- Extending Half-life by Indirect Targeting of the Neonatal Fc Receptor (FcRn) Using a Minimal Albumin Binding Domain
- (2010) Jan Terje Andersen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Novel GLP-1 Fusion Chimera as Potent Long Acting GLP-1 Receptor Agonist
- (2010) Qinghua Wang et al. PLoS One
- The effects of affinity and valency of an albumin-binding domain (ABD) on the half-life of a single-chain diabody-ABD fusion protein
- (2010) J. Hopp et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Unraveling the Science of Incretin Biology
- (2009) Michael A. Nauck AMERICAN JOURNAL OF MEDICINE
- Safety, tolerability, pharmacodynamics and pharmacokinetics of albiglutide, a long-acting glucagon-like peptide-1 mimetic, in healthy subjects
- (2009) M. A. Bush et al. DIABETES OBESITY & METABOLISM
- An Albumin-Exendin-4 Conjugate Engages Central and Peripheral Circuits Regulating Murine Energy and Glucose Homeostasis
- (2008) Laurie L. Baggio et al. GASTROENTEROLOGY
- Design and Synthesis of Conformationally Constrained Glucagon-Like Peptide-1 Derivatives with Increased Plasma Stability and Prolonged in Vivo Activity
- (2008) Les P. Miranda et al. JOURNAL OF MEDICINAL CHEMISTRY
- Influence of Selective Fluorination on the Biological Activity and Proteolytic Stability of Glucagon-like Peptide-1
- (2008) He Meng et al. JOURNAL OF MEDICINAL CHEMISTRY
- Angiotensin-(1-7) with Thioether Bridge: An Angiotensin-Converting Enzyme-Resistant, Potent Angiotensin-(1-7) Analog
- (2008) L. D. Kluskens et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Anti-serum albumin domain antibodies for extending the half-lives of short lived drugs
- (2008) L. J. Holt et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Engineering of a femtomolar affinity binding protein to human serum albumin
- (2008) A. Jonsson et al. PROTEIN ENGINEERING DESIGN & SELECTION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now